A Study to Evaluate the Safety & Efficacy of Lenvatinib in Participants

See also
Status	Clinical Trial	Phase
Completed	`NCT00537095` - Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer	Phase 2
Recruiting	`NCT04139096` - Genetic Susceptibility to Radiation Induced Thyroid Cancer
Completed	`NCT00754182` - Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision	N/A
Completed	`NCT00094055` - Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer	Phase 2
Completed	`NCT00148213` - Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma	N/A
Recruiting	`NCT06398795` - Dual-port Trans-subclavian Thyroid Endoscopic Surgery	N/A
Recruiting	`NCT01005654` - Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Active, not recruiting	`NCT05579782` - Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy	N/A
Completed	`NCT01437254` - To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer	Phase 1
Recruiting	`NCT03160274` - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Completed	`NCT00984282` - Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer	Phase 3
Completed	`NCT01292044` - The Role of Elastography in the Diagnosis of Thyroid Nodules	N/A
Terminated	`NCT04644315` - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Phase 2
Active, not recruiting	`NCT02418247` - Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer	Phase 2/Phase 3
Completed	`NCT00467506` - Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma	Phase 2
Completed	`NCT02430714` - Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Recruiting	`NCT04396912` - Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort
Enrolling by invitation	`NCT04411290` - Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
Recruiting	`NCT04410601` - Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT	N/A
Completed	`NCT03469310` - Minimizing Narcotic Analgesics After Endocrine Surgery	Phase 4

NCT number	NCT03573960
Study type	Interventional
Source	Eisai Inc.
Contact
Status	Active, not recruiting
Phase	Phase 4
Start date	April 1, 2018
Completion date	May 1, 2024

A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms